procyanidin has been researched along with Mouth Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Hatano, T; Ito, H; Itoh, Y; Kobayashi, E; Kusama, K; Li, SH; Sakagami, H; Satoh, K; Shimura, S; Sugita, D; Takamatsu, Y; Yoshida, T | 1 |
| Mei, B; Sun, Q; Xiao, Q; Zhang, T; Zhang, X | 1 |
| Chen, SF; Lin, YS; Liu, CL; Nieh, S | 1 |
| Bergman, CJ; Chokshi, SB; Hill, CK; Keiserman, MA; Kingsley, K; Low, E; Phipps, D; Truong, K; West, MA | 1 |
| Dye, J; Halthore, VS; Jensen, D; Kingsley, K; Martin, D; O'Malley, S; Phippen, S; Ross, D; Toponce, R | 1 |
| Chatelain, K; Farris, D; Jensen, D; King, M; Kingsley, K; O'Malley, S; Pickup, J; Swapp, A | 1 |
6 other study(ies) available for procyanidin and Mouth Neoplasms
| Article | Year |
|---|---|
Polyphenols from Eriobotrya japonica and their cytotoxicity against human oral tumor cell lines.
Topics: Antibodies, Monoclonal; Antineoplastic Agents, Phytogenic; Apoptosis; Biflavonoids; Catechin; DNA Fragmentation; Drug Screening Assays, Antitumor; Electrophoresis, Agar Gel; Flavonoids; Glycosides; Humans; Immunohistochemistry; Molecular Weight; Mouth Neoplasms; Phenols; Plants, Medicinal; Proanthocyanidins; Tumor Cells, Cultured | 2000 |
Procyanidin B2 inhibits angiogenesis and cell growth in oral squamous cell carcinoma cells through the vascular endothelial growth factor (VEGF)/VEGF receptor 2 (VEGFR2) pathway.
Topics: Biflavonoids; Catechin; Cell Line, Tumor; Cell Proliferation; Humans; Mouth Neoplasms; Neovascularization, Pathologic; Proanthocyanidins; Squamous Cell Carcinoma of Head and Neck; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2022 |
The chemoadjuvant potential of grape seed procyanidins on p53-related cell death in oral cancer cells.
Topics: Anticarcinogenic Agents; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Dose-Response Relationship, Drug; G1 Phase; Grape Seed Extract; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mitochondria; Mouth Neoplasms; Neoplasm Invasiveness; Oncogene Proteins; Plant Preparations; Point Mutation; Proanthocyanidins; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Tumor Suppressor Protein p53; Vitis | 2012 |
Soy protein extract (SPE) exhibits differential in vitro cell proliferation effects in oral cancer and normal cell lines.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Caspase 2; Caspase 8; Cell Cycle; Cell Line; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Glycine max; Humans; Isoflavones; Mouth Neoplasms; Ornithine Decarboxylase; Phytotherapy; Plant Preparations; Proanthocyanidins; RNA, Messenger; Seeds; Soybean Proteins | 2011 |
Inhibition of oral cancer growth in vitro is modulated through differential signaling pathways by over-the-counter proanthocyanidin supplements.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Squamous Cell; Cell Cycle; Cell Line; Cell Line, Tumor; Cell Proliferation; Dietary Supplements; Humans; Mouth Neoplasms; Nonprescription Drugs; Phytotherapy; Plant Extracts; Proanthocyanidins; RNA, Messenger; Seeds; Signal Transduction; Vitis | 2010 |
Oral squamous cell carcinoma proliferative phenotype is modulated by proanthocyanidins: a potential prevention and treatment alternative for oral cancer.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Female; Fibroblasts; Human papillomavirus 16; Humans; Mouth Neoplasms; Papillomavirus Infections; Phenotype; Proanthocyanidins; Uterine Cervical Neoplasms | 2007 |